Translational Research in Malignancies Members
The Translational Research in Malignancies (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Abaza, Yasmin
Assistant Professor
Bio
I am a clinical researcher with a specialized focus on targeted therapies for patients with myeloid malignancies. I have completed two fellowships in Hematology/Oncology and Leukemia at UCLA and ... [more]
Abazeed, Mohamed
Associate Professor
Bio
As a physician scientist trained in clinical oncology, genetics, cancer genomics, computational biology machine learning and biostatistics, I am interested in basic research to discover mechanisms tha... [more]
Abdulkadir, Sarki
Professor
Bio
My research has focused on deciphering the molecular mechanisms that drive epithelial cancer initiation, progression and recurrence with an emphasis on prostate cancer. My lab has been active in estab... [more]
Adekola, Kehinde
Associate Professor
Bio
To improve the survival outcomes for hematologic malignancies and the opportunity to study Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in individuals of African descent pre... [more]
Adli, Mazhar
Associate Professor
Bio
I obtained my Ph.D. training in cancer biology and postdoc training in the large-scale human genome and epigenome mapping projects provides me a unique set of experimental and analytical skills to exe... [more]
Altman, Jessica
Professor
Bio
My primary research efforts are based on increasing understanding of the role of aberrant signal transduction pathways in the development of myeloid neoplasms; defining molecular targets for the ... [more]